Impact of pre-analytical parameters on the measurement of circulating microparticles: Towards standardization of protocol

Journal of Thrombosis and Haemostasis

Volumn 10, Issue 3, 2012, Pages 437-446

  Lacroix, R ^a,b   Judicone, C ^c   Poncelet, P ^c   Robert, S ^a   Arnaud, L ^b   Sampol, J ^a   Dignat George, F ^a,b  

^a INSERM   (France)

^b HÔPITAL DE LA CONCEPTION   (France)

^c Biocytex   (France)

Author keywords

Microparticles; Pre analytics; Standardization

Indexed keywords

PROCOAGULANT; THROMBIN;

ADULT; AGITATION; ANALYTICAL PARAMETERS; ARTICLE; BLOOD CLOTTING TIME; CENTRIFUGATION; FEMALE; FLOW CYTOMETRY; FREEZING; HEMATOLOGICAL PARAMETERS; HUMAN; HUMAN TISSUE; MALE; MEMBRANE MICROPARTICLE; NORMAL HUMAN; PHLEBOTOMY; PRIORITY JOURNAL; THROMBIN TIME;

ADULT; ANTICOAGULANTS; BIOLOGICAL MARKERS; BLOOD COAGULATION; BLOOD COAGULATION TESTS; CELL-DERIVED MICROPARTICLES; CENTRIFUGATION; CRYOPRESERVATION; FEMALE; FLOW CYTOMETRY; FREEZING; HUMANS; MALE; MIDDLE AGED; PHLEBOTOMY; PRACTICE GUIDELINES AS TOPIC; SPECIMEN HANDLING; THROMBIN; TIME FACTORS; YOUNG ADULT;

EID: 84857560160     PISSN: 15387933     EISSN: 15387836     Source Type: Journal    
DOI: 10.1111/j.1538-7836.2011.04610.x     Document Type: Article

References (46)

1. Freyssinet JM, Dignat-George F. More on: measuring circulating cell-derived microparticles. J Thromb Haemost 2005; 3: 613-14.
2. Al-Nedawi K, Meehan B, Rak J. Microvesicles: messengers and mediators of tumor progression. Cell Cycle. 2009; 8: 2014-18.
3. Davizon P, Lopez JA. Microparticles and thrombotic disease. Curr Opin Hematol 2009; 16: 334-41.
4. Ardoin SP, Shanahan JC, Pisetsky DS. The role of microparticles in inflammation and thrombosis. Scand J Immunol 2007; 66: 159-65.
5. Boulanger CM, Amabile N, Tedgui A. Circulating microparticles: a potential prognostic marker for atherosclerotic vascular disease. Hypertension. 2006; 48: 180-6.
6. Diamant M, Tushuizen ME, Sturk A, Nieuwland R. Cellular microparticles: new players in the field of vascular disease? Eur J Clin Invest 2004; 34: 392-401.
7. Zwicker JI, Liebman HA, Neuberg D, Lacroix R, Bauer KA, Furie BC, Furie B. Tumor-derived tissue factor-bearing microparticles are associated with venous thromboembolic events in malignancy. Clin Cancer Res 2009; 15: 6830-40.
8. Morel O, Toti F, Hugel B, Bakouboula B, Camoin-Jau L, Dignat-George F, Freyssinet JM. Procoagulant microparticles: disrupting the vascular homeostasis equation? Arterioscler Thromb Vasc Biol 2006; 26: 2594-604.
9. Sabatier F, Camoin-Jau L, Anfosso F, Sampol J, Dignat-George F. Circulating endothelial cells, microparticles and progenitors: key players towards the definition of vascular competence. J Cell Mol Med 2009; 13: 454-71.
10. Shet AS. Characterizing blood microparticles: technical aspects and challenges. Vasc Health Risk Manag. 2008; 4: 769-74.
11. Enjeti AK, Lincz LF, Seldon M. Detection and measurement of microparticles: an evolving research tool for vascular biology. Semin Thromb Hemost 2007; 33: 771-9.
12. Piccin A, Murphy WG, Smith OP. Circulating microparticles: pathophysiology and clinical implications. Blood Rev 2007; 21: 157-71.
13. Rubin O, Crettaz D, Tissot JD, Lion N. Pre-analytical and methodological challenges in red blood cell microparticle proteomics. Talanta 2010; 82: 1-8.
14. Hind E, Heugh S, Ansa-Addo EA, Antwi-Baffour S, Lange S, Inal J. Red cell PMVs, plasma membrane-derived vesicles calling out for standards. Biochem Biophys Res Commun 2010; 399: 465-9.
15. Jy W, Horstman LL, Jimenez JJ, Ahn YS. Measuring circulating cell-derived microparticles. J Thromb Haemost 2004; 2: 1842-51.
16. Polack B, Schved JF, Boneu B. Preanalytical recommendations of the 'Groupe d'Etude sur l'Hemostase et la Thrombose' (GEHT) for venous blood testing in hemostasis laboratories. Haemostasis. 2001; 31: 61-8.
17. Lippi G, Salvagno GL, Montagnana M, Poli G, Guidi GC. Influence of the needle bore size on platelet count and routine coagulation testing. Blood Coagul Fibrinolysis 2006; 17: 557-61.
18. Hefler L, Grimm C, Leodolter S, Tempfer C. To butterfly or to needle: the pilot phase. Ann Intern Med 2004; 140: 935-6.
19. van Ierssel SH, Van Craenenbroeck EM, Conraads VM, Van Tendeloo VF, Vrints CJ, Jorens PG, Hoymans VY. Flow cytometric detection of endothelial microparticles (EMP): effects of centrifugation and storage alter with the phenotype studied. Thromb Res 2010; 125: 332-9.
20. Lippi G, Salvagno GL, Brocco G, Guidi GC. Preanalytical variability in laboratory testing: influence of the blood drawing technique. Clin Chem Lab Med 2005; 43: 319-25.
21. Lippi G, Franchini M, Montagnana M, Salvagno GL, Poli G, Guidi GC. Quality and reliability of routine coagulation testing: can we trust that sample? Blood Coagul Fibrinolysis 2006; 17: 513-19.
22. Lippi G, Guidi GC, Mattiuzzi C, Plebani M. Preanalytical variability: the dark side of the moon in laboratory testing. Clin Chem Lab Med 2006; 44: 358-65.
23. Gritters M, Grooteman MP, Schoorl M, Bartels PC, Scheffer PG, Teerlink T, Schalkwijk CG, Spreeuwenberg M, Nube MJ. Citrate anticoagulation abolishes degranulation of polymorphonuclear cells and platelets and reduces oxidative stress during haemodialysis. Nephrol Dial Transplant 2006; 21: 153-9.
24. Morel O, Toti F, Jesel L, Freyssinet JM. Mechanisms of microparticle generation: on the trail of the mitochondrion!. Semin Thromb Hemost 2010; 36: 833-44.
25. Philippe J, De Logi E, Baele G. Comparison of five different citrated tubes and their in vitro effects on platelet activation. Clin Chem 2004; 50: 656-8.
26. Lippi G, Salvagno GL, Adcock DM, Gelati M, Guidi GC, Favaloro EJ. Right or wrong sample received for coagulation testing? Tentative algorithms for detection of an incorrect type of sample. Int J Lab Hematol. 2010; 32: 132-8.
27. Mody M, Lazarus AH, Semple JW, Freedman J. Preanalytical requirements for flow cytometric evaluation of platelet activation: choice of anticoagulant. Transfus Med 1999; 9: 147-54.
28. Kim HK, Song KS, Lee ES, Lee YJ, Park YS, Lee KR, Lee SN. Optimized flow cytometric assay for the measurement of platelet microparticles in plasma: pre-analytic and analytic considerations. Blood Coagul Fibrinolysis 2002; 13: 393-7.
29. Pearson L, Thom J, Adams M, Oostryck R, Krueger R, Yong G, Baker R. A rapid flow cytometric technique for the detection of platelet-monocyte complexes, activated platelets and platelet-derived microparticles. Int J Lab Hematol. 2009; 31: 430-9.
30. Keuren JF, Magdeleyns EJ, Govers-Riemslag JW, Lindhout T, Curvers J. Effects of storage-induced platelet microparticles on the initiation and propagation phase of blood coagulation. Br J Haematol 2006; 134: 307-13.
31. Rubin O, Crettaz D, Canellini G, Tissot JD, Lion N. Microparticles in stored red blood cells: an approach using flow cytometry and proteomic tools. Vox Sang 2008; 95: 288-97.
32. Yuana Y, Bertina RM, Osanto S. Pre-analytical and analytical issues in the analysis of blood microparticles. Thromb Haemost 2011; 105: 396-408.
33. Dignat-George F, Sabatier F, Camoin L, Sampol J. Numeration of circulating microparticles of various cellular origin by flow cytometry. J Thromb Haemost 2004; 2: 1844-5.
34. Robert S, Poncelet P, Lacroix R, Arnaud L, Giraudo L, Hauchard A, Sampol J, Dignat-George F. Standardization of platelet-derived microparticle counting using calibrated beads and a Cytomics FC500 routine flow cytometer: a first step towards multicenter studies? J Thromb Haemost 2009; 7: 190-7.
35. Biro E, Nieuwland R, Sturk A. Measuring circulating cell-derived microparticles. J Thromb Haemost 2004; 2: 1843-4.
36. Hugel B, Zobairi F, Freyssinet JM. Measuring circulating cell-derived microparticles. J Thromb Haemost 2004; 2: 1842-51.
37. Dignat-George F, Sabatier F, Camoin-Jau L, Sampol J. Measuring circulating cell-derived microparticles. J Thromb Haemost 2004; 2: 1842-51.
38. Nantakomol D, Imwong M, Soontarawirat I, Kotjanya D, Khakhai C, Ohashi J, Nuchnoi P. The absolute counting of red cell-derived microparticles with red cell bead by flow rate based assay. Cytometry B Clin Cytom. 2009; 76: 191-8.
39. Ayers L, Kohler M, Harrison P, Sargent I, Dragovic R, Schaap M, Nieuwland R, Brooks SA, Ferry B. Measurement of circulating cell-derived microparticles by flow cytometry: sources of variability within the assay. Thromb Res 2011; 127: 370-7.
40. Shet AS, Aras O, Gupta K, Hass MJ, Rausch DJ, Saba N, Koopmeiners L, Key NS, Hebbel RP. Sickle blood contains tissue factor-positive microparticles derived from endothelial cells and monocytes. Blood 2003; 102: 2678-83.
41. Ahmad S, Amirkhosravi A, Langer F, Desai H, Amaya M, Francis JL. Importance of pre-analytical variables in the measurement of platelet derived microparticles. J Thromb Haemost 2005; 3: 372.
42. Simak J, Holada K, Risitano AM, Zivny JH, Young NS, Vostal JG. Elevated circulating endothelial membrane microparticles in paroxysmal nocturnal haemoglobinuria. Br J Haematol 2004; 125: 804-13.
43. Biro E, Nieuwland R, Sturk A. Measuring circulating cell-derived microparticles. J Thromb Haemost 2004; 2: 1842-51.
44. Biro E, Sturk-Maquelin KN, Vogel GM, Meuleman DG, Smit MJ, Hack CE, Sturk A, Nieuwland R. Human cell-derived microparticles promote thrombus formation in vivo in a tissue factor-dependent manner. J Thromb Haemost 2003; 1: 2561-8.
45. Simak J, Gelderman MP. Cell membrane microparticles in blood and blood products: potentially pathogenic agents and diagnostic markers. Transfus Med Rev 2006; 20: 1-26.
46. Trummer A, De Rop C, Tiede A, Ganser A, Eisert R. Recovery and composition of microparticles after snap-freezing depends on thawing temperature. Blood Coagul Fibrinolysis 2009; 20: 52-6.